Shattuck Labs, Inc. (STTK)
Data as of , from SEC Form 4 filings.
See up to 3 months of STTK. The 7-day demo opens the 1M and 3M ranges and puts STTK on your watchlist.
Start 7-day demoLatest STTK insider trades
About Shattuck Labs, Inc. (STTK)
The SEC lists Shattuck Labs, Inc. under CIK 0001680367, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
STTK Form 4 activity by transaction type, last 90 days
No Form 4 activity for STTK in the last 90 days.
STTK insider transactions (Form 4)
4353 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Andrew R. Neill - Officer | Tax withholding / forfeiture | Common Stock | 6,660 | $4.75 | $32K | |
| Andrew R. Neill - Officer | Grant or award | Stock Option (Right to Buy) | 549,800 | $0.00 | - | |
| Taylor Schreiber - Officer | Grant or award | Stock Option (Right to Buy) | 1,548,300 | $0.00 | - | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Common Stock | 5,255,106 | $0.87 | $4.56M | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Common Stock | 1,051,021 | $0.87 | $912K | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Pre-Funded Warrants (right to buy) | 10,111,384 | - | - | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Pre-Funded Warrants (right to buy) | 2,022,277 | - | - | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Common Warrants (right to buy) | 15,366,490 | - | - | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Common Warrants (right to buy) | 3,073,298 | - | - | |
| Mona Ashiya - Director | Open-market purchase | Common Stock | 5,255,106 | $0.87 | $4.56M | |
| Mona Ashiya - Director | Open-market purchase | Common Stock | 1,051,021 | $0.87 | $912K | |
| Mona Ashiya - Director | Open-market purchase | Pre-Funded Warrants (right to buy) | 10,111,384 | - | - | |
| Mona Ashiya - Director | Open-market purchase | Pre-Funded Warrants (right to buy) | 2,022,277 | - | - | |
| Mona Ashiya - Director | Open-market purchase | Common Warrants (right to buy) | 15,366,490 | - | - | |
| Mona Ashiya - Director | Open-market purchase | Common Warrants (right to buy) | 3,073,298 | - | - | |
| Mona Ashiya | Grant or award | Stock Option (Right to Buy) | 66,300 | $0.00 | - | |
| Daniel G. Baker | Grant or award | Stock Option (Right to Buy) | 66,300 | $0.00 | - | |
| Andrew R. Neill - Officer | Grant or award | Common Stock | 64,027 | $0.87 | $56K | |
| Andrew R. Neill - Officer | Grant or award | Warrants (Right to Buy) | 64,027 | - | - | |
| Stephen Stout - Officer | Grant or award | Common Stock | 12,805 | $0.87 | $11K | |
| Stephen Stout - Officer | Grant or award | Warrants (Right to Buy) | 12,805 | - | - | |
| Abhinav A. Shukla - Officer | Grant or award | Common Stock | 5,122 | $0.87 | $4K | |
| Abhinav A. Shukla - Officer | Grant or award | Warrants (Right to Buy) | 5,122 | - | - | |
| Taylor Schreiber - Officer | Grant or award | Common Stock | 25,610 | $0.87 | $22K | |
| Taylor Schreiber - Officer | Grant or award | Warrants (Right to Buy) | 25,610 | - | - | |
| Redmile Group, LLC - Director | Grant or award | Pre-Funded Warrants to Purchase Common Stock | 4,097,730 | - | - | |
| Redmile Group, LLC - Director | Grant or award | Common Warrants to Purchase Common Stock | 4,097,730 | - | - | |
 Clay B. Siegall | Grant or award | Common Stock | 128,054 | $0.87 | $111K | |
| Clay B. Siegall | Grant or award | Warrants (Right to Buy) | 128,054 | - | - | |
| Michael Stewart Lee - Director | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| Amy Kate Sasser | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| Carrie Brownstein | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| Tyler Brous | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| Helen M. Boudreau | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| George Golumbeski | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| Neil W. Gibson | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| Redmile Group, LLC - Director | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| Clay B. Siegall | Grant or award | Stock Option (Right to Buy) | 33,150 | $0.00 | - | |
| Redmile Group, LLC - Director | Open-market sale | Common Stock, par value $0.0001 per share | 133,371 | $1.25 | $167K | |
| Redmile Group, LLC - Director | Open-market purchase | Common Stock, par value $0.0001 per share | 133,371 | $1.25 | $167K | |
| Redmile Group, LLC - Director | Other | Common Stock, par value $0.0001 per share | 1,026,888 | $1.25 | $1.28M | |
| Redmile Group, LLC - Director | Other | Common Stock, par value $0.0001 per share | 1,026,888 | $1.25 | $1.28M | |
| Taylor Schreiber - Officer | Open-market purchase | Common Stock | 36,500 | $1.21 | $44K |
Recent STTK Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
STTK insider trading FAQ
What is the latest insider trade for STTK?
Shattuck Labs, Inc. (STTK) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-07. The full record for STTK runs to 53 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying STTK stock?
No insider purchases of STTK were filed in the last 90 days. 19 purchases are on record for this company.
How many insiders are selling STTK stock?
No insider sales of STTK were filed in the last 90 days. 7 sales are on record for this company.
Where can I see STTK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects STTK Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Abhinav A. Shukla view on EDGAR
- - Abhinav A. Shukla view on EDGAR
- - Arundathy N. Pandite view on EDGAR
- - Mona Ashiya view on EDGAR
- - ORBIMED ADVISORS LLC view on EDGAR
- - Clay B. Siegall view on EDGAR
- - ORBIMED ADVISORS LLC view on EDGAR
- - Mona Ashiya view on EDGAR
- - Daniel G. Baker view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where STTK's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow STTK with a 7-day demo
- STTK on your watchlist
- Every STTK Form 4 filing on record
- Up to 3 months of STTK price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
